相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
John B. Buse et al.
DIABETOLOGIA (2020)
Cardiovascular outcomes trials with incretin-based medications: a critical review of data available on GLP-1 receptor agonists and DPP-4 inhibitors
Alexandros Sachinidis et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2020)
Microvascular and macrovascular effects of liraglutide
Domenico Cianflone et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2019)
A glucagon-like peptide-1 analog, liraglutide, ameliorates endothelial dysfunction through miRNAs to inhibit apoptosis in rats
Qian Zhang et al.
PEERJ (2019)
Effect of Hypoxia-Induced MicroRNA-210 Expression on Cardiovascular Disease and the Underlying Mechanism
Yinuo Guan et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)
Diabetes Increases Risk of Gastric Cancer After Helicobacter pylori Eradication: A Territory-Wide Study With Propensity Score Analysis
Ka Shing Cheung et al.
DIABETES CARE (2019)
MicroRNA-130a modulates a radiosensitivity of rectal cancer by targeting SOX4
Huyen Trang Ha Thi et al.
NEOPLASIA (2019)
Cardiovascular outcomes of liraglutide in patients with type 2 diabetes A systematic review and meta-analysis
Chun-Mei Duan et al.
MEDICINE (2019)
GLP-1 receptor agonists and cardiovascular outcome trials: An update
Eirini Andrikou et al.
HELLENIC JOURNAL OF CARDIOLOGY (2019)
Liraglutide prevents β-cell apoptosis via inactivation of NOX2 and its related signaling pathway
Min Ding et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2019)
Elucidating the contributory role of microRNA to cardiovascular diseases (a review)
Jason L. Johnson
VASCULAR PHARMACOLOGY (2019)
New insights into oxidative stress and inflammation during diabetes mellitus-accelerated atherosclerosis
Ting Yuan et al.
REDOX BIOLOGY (2019)
MicroRNAs as therapeutic targets for the treatment of diabetes mellitus and its complications
Romano Regazzi
EXPERT OPINION ON THERAPEUTIC TARGETS (2018)
Myocardial reparative functions of exosomes from mesenchymal stem cells are enhanced by hypoxia treatment of the cells via transferring microRNA-210 in an nSMase2-dependent way
Jinyun Zhu et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2018)
Natural approaches in metabolic syndrome management
Angelo Maria Patti et al.
ARCHIVES OF MEDICAL SCIENCE (2018)
GLP-1 receptor agonists and reduction of cardiometabolic risk: Potential underlying mechanisms
Manfredi Rizzo et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)
Liraglutide regulates the viability of pancreatic alpha-cells and pancreatic beta-cells through cAMP-PKA signal pathway
Xuejuan Xu et al.
LIFE SCIENCES (2018)
MicroRNAs and type 2 diabetes mellitus: Molecular mechanisms and the effect of antidiabetic drug treatment
Habib Yaribeygi et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2018)
Liraglutide inhibits the proliferation and promotes the apoptosis of MCF-7 human breast cancer cells through downregulation of microRNA-27a expression
Wei Zhao et al.
MOLECULAR MEDICINE REPORTS (2018)
Liraglutide reduces hepatic glucolipotoxicity-induced liver cell apoptosis through NRF2 signaling in Zucker diabetic fatty rats
Jun Guo et al.
MOLECULAR MEDICINE REPORTS (2018)
MicroRNA-130a inhibits the proliferation, migration and invasive ability of hepatocellular carcinoma cells by downregulating Rho-kinase 2
Yansong Zheng et al.
MOLECULAR MEDICINE REPORTS (2018)
Atrial overexpression of microRNA-27b attenuates angiotensin II-induced atrial fibrosis and fibrillation by targeting ALK5
Yanshan Wang et al.
HUMAN CELL (2018)
Glucagon Like Peptide 1 and MicroRNA in Metabolic Diseases: Focusing on GLP1 Action on miRNAs
Barbara Capuani et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
MicroRNA-210 Enhances Fibrous Cap Stability in Advanced Atherosclerotic Lesions
Suzanne M. Eken et al.
CIRCULATION RESEARCH (2017)
Regulation of TGF-β-mediated endothelial-mesenchymal transition by microRNA-27
Hiroshi I. Suzuki et al.
JOURNAL OF BIOCHEMISTRY (2017)
Lifestyle recommendations for the prevention and management of metabolic syndrome: an international panel recommendation
Pablo Perez-Martinez et al.
NUTRITION REVIEWS (2017)
Nutrimiromics: Role of microRNAs and Nutrition in Modulating Inflammation and Chronic Diseases
Bruna J. Quintanilha et al.
NUTRIENTS (2017)
Circular RNAs promote TRPM3 expression by inhibiting hsa-miR-130a-3p in coronary artery disease patients
Ren-You Pan et al.
ONCOTARGET (2017)
Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist Liraglutide Alters Bone Marrow Exosome-Mediated miRNA Signal Pathways in Ovariectomized Rats with Type 2 Diabetes
Jin Li et al.
MEDICAL SCIENCE MONITOR (2017)
Downregulation of miR-139-5p contributes to the antiapoptotic effect of liraglutide on the diabetic rat pancreas and INS-1 cells by targeting IRS1
Jin Li et al.
PLOS ONE (2017)
Elevated miR-130a/miR130b/miR152 expression reduces intracellular ATP levels in the pancreatic beta cell
Jones K. Ofori et al.
SCIENTIFIC REPORTS (2017)
Chronic Complications of Diabetes Mellitus: A Mini Review
Mohamed Lotfy et al.
CURRENT DIABETES REVIEWS (2017)
Predictive Effects of Circulating miR-221, miR-130a and miR-155 for Coronary Heart Disease: A Multi-Ethnic Study in China
Qiao-Wei Jia et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
MicroRNA-210 alleviates oxidative stress-associated cardiomyocyte apoptosis by regulating BNIP3
Hongying Diao et al.
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2017)
Protective Effect of let-7 miRNA Family in Regulating Inflammation in Diabetes-Associated Atherosclerosis
Eoin Brennan et al.
DIABETES (2017)
Type 2 diabetes mellitus and risk of hepatocellular carcinoma: spotlight on nonalcoholic fatty liver disease
Alessandro Mantovani et al.
ANNALS OF TRANSLATIONAL MEDICINE (2017)
Is Targeting microRNAs the Philosopher's Stone for Vascular Disease?
Vasilios G. Athyros et al.
CURRENT VASCULAR PHARMACOLOGY (2016)
Circulating miR-130a, miR-27b, and miR-210 in Patients With Peripheral Artery Disease and Their Potential Relationship With Oxidative Stress: A Pilot Study
Salvatore Santo Signorelli et al.
ANGIOLOGY (2016)
miRNA-27b modulates endothelial cell angiogenesis by directly targeting Naa15 in atherogenesis
Li Qun et al.
ATHEROSCLEROSIS (2016)
Liraglutide improves metabolic parameters and carotid intima-media thickness in diabetic patients with the metabolic syndrome: an 18-month prospective study
Manfredi Rizzo et al.
CARDIOVASCULAR DIABETOLOGY (2016)
Once-Daily Liraglutide Versus Lixisenatide as Add-on to Metformin in Type 2 Diabetes: A 26-Week Randomized Controlled Clinical Trial
Michael Nauck et al.
DIABETES CARE (2016)
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
Alberico L. Catapano et al.
EUROPEAN HEART JOURNAL (2016)
Inhibitory effect of microRNA-27b on interleukin 17 (IL-17)-induced monocyte chemoattractant protein-1 (MCP1) expression
K. D. Huang et al.
GENETICS AND MOLECULAR RESEARCH (2016)
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Steven P. Marso et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Bergamot Reduces Plasma Lipids, Atherogenic Small Dense LDL, and Subclinical Atherosclerosis in Subjects with Moderate Hypercholesterolemia: A 6 Months Prospective Study
Peter P. Toth et al.
FRONTIERS IN PHARMACOLOGY (2016)
GLP-1 contributes to increases in PGC-1α expression by downregulating miR-23a to reduce apoptosis
Chi Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
MicroRNA-130a Targets MAP3K12 to Modulate Diabetic Endothelial Progenitor Cell Function
Meng Ye et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)
microRNAs: Potential Targets for the Treatment of Cardiovascular Disease
Vasilios G. Athyros et al.
CURRENT VASCULAR PHARMACOLOGY (2015)
Liraglutide improves carotid intima-media thickness in patients with type 2 diabetes and non-alcoholic fatty liver disease: an 8-month prospective pilot study
Ali A. Rizvi et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2015)
MicroRNAs in cardiovascular disease: an introduction for clinicians
Simon P. R. Romaine et al.
HEART (2015)
Liraglutide Reduces Oxidative Stress And Restores Heme Oxygenase-1 and Ghrelin Levels in Patients with Type 2 Diabetes: A Prospective Pilot Study
Manfredi Rizzo et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
MicroRNA Therapeutics: the Next Magic Bullet?
Bridget Simonson et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2015)
Induction of miR-132 and miR-212 Expression by Glucagon-Like Peptide 1 (GLP-1) in Rodent and Human Pancreatic β-Cells
Jin Shang et al.
MOLECULAR ENDOCRINOLOGY (2015)
Targeting of RUNX3 by miR-130a and miR-495 cooperatively increases cell proliferation and tumor angiogenesis in gastric cancer cells
Sun Hee Lee et al.
ONCOTARGET (2015)
The Risk of Colorectal Cancer in Patients With Type 2 Diabetes: Associations With Treatment Stage and Obesity
Paul J. H. L. Peeters et al.
DIABETES CARE (2015)
Hypoxia-Induced miR-210 Modulates Tissue Response to Acute Peripheral Ischemia
Germana Zaccagnini et al.
ANTIOXIDANTS & REDOX SIGNALING (2014)
Cardiovascular microRNAs: as modulators and diagnostic biomarkers of diabetic heart disease
Shruti Rawal et al.
CARDIOVASCULAR DIABETOLOGY (2014)
Liraglutide decreases carotid intima-media thickness in patients with type 2 diabetes: 8-month prospective pilot study
Manfredi Rizzo et al.
CARDIOVASCULAR DIABETOLOGY (2014)
Incretin-Based Therapies, Glucometabolic Health and Endovascular Inflammation
Manfredi Rizzo et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
Neil J. Stone et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
MiR-27 orchestrates the transcriptional regulation of brown adipogenesis
Lei Sun et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2014)
MicroRNA Microarray Expression Profiling in Human Myocardial Infarction
Emanuela Boštjančič et al.
DISEASE MARKERS (2013)
MicroRNA-27b Is a Regulatory Hub in Lipid Metabolism and Is Altered in Dyslipidemia
Kasey C. Vickers et al.
HEPATOLOGY (2013)
MicroRNA-27 (miR-27) Targets Prohibitin and Impairs Adipocyte Differentiation and Mitochondria! Function in Human Adipose-derived Stem Cells
Ting Kang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Brown and beige fat: development, function and therapeutic potential
Matthew Harms et al.
NATURE MEDICINE (2013)
Angiogenesis is controlled by miR-27b associated with endothelial tip cells
Sonia A. Melo et al.
BLOOD (2012)
MicroRNA Modulation in Obesity and Periodontitis
R. Perri et al.
JOURNAL OF DENTAL RESEARCH (2012)
Identification of miR-130a, miR-27b and miR-210 as serum biomarkers for atherosclerosis obliterans
Tianrun Li et al.
CLINICA CHIMICA ACTA (2011)
miR-210: More than a silent player in hypoxia
Cecilia Devlin et al.
IUBMB LIFE (2011)
MicroRNA-210 as a Novel Therapy for Treatment of Ischemic Heart Disease
Shijun Hu et al.
CIRCULATION (2010)
Plasma MicroRNA Profiling Reveals Loss of Endothelial MiR-126 and Other MicroRNAs in Type 2 Diabetes
Anna Zampetaki et al.
CIRCULATION RESEARCH (2010)
Glucose lowering and anti-atherogenic effects of incretin-based therapies: GLP-1 analogues and DPP-4-inhibitors
Manfredi Rizzo et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
Small interference RNA against PTP-1B reduces hypoxia/reoxygenation induced apoptosis of rat cardiomyocytes
Huiwen Song et al.
APOPTOSIS (2008)
Endothelial dysfunction and carotid lesions are strong predictors of clinical events in patients with early stages of atherosclerosis: a 24-month follow-up study
Egle Corrado et al.
CORONARY ARTERY DISEASE (2008)
MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3
Pasquale Fasanaro et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Obesity and cardiovascular disease - Pathophysiology, evaluation, and effect of weight loss
P Poirier et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
分享论文
